In Vivo

What In Vivo Includes

In vivo research encompasses:

Type	Description
Animal studies	Testing in mice, rats, primates, etc.
Human trials	Clinical trials (Phases I-IV)
Observational	Studying natural processes in living systems

In Vivo vs In Vitro Comparison

Factor	In Vivo	In Vitro
Complexity	Full biological systems	Isolated components
ADME	Real pharmacokinetics	No absorption/distribution
Immune response	Present	Absent
Off-target effects	Detectable	May be missed
Cost/time	Higher	Lower
Ethical considerations	Significant	Fewer

Why In Vivo Studies Are Essential

In vitro can’t replicate:

• Blood circulation and distribution
• Metabolic processing
• Organ system interactions
• Immune responses
• Natural feedback mechanisms

Preclinical In Vivo Studies

Animal Models for Peptides

Model	Common Uses
Mice	Initial efficacy, genetics studies
Rats	Metabolic studies, toxicology
Dogs	Cardiovascular, PK studies
Primates	Human-relevant data (when necessary)

What’s Tested

• Safety and toxicology
• Pharmacokinetics (ADME)
• Efficacy (does it work?)
• Dose-response relationships
• Biomarker changes

In Vivo Progression for Peptide Drugs

In Vitro Studies (receptor binding, cell effects)
              ↓
Rodent Studies (mice, rats)
              ↓
Larger Animal Studies (if needed)
              ↓
Phase I Human Trials (safety)
              ↓
Phase II Human Trials (efficacy)
              ↓
Phase III Human Trials (confirmation)
              ↓
FDA Approval & Phase IV

Challenges in In Vivo Peptide Research

Species Differences

• Animal receptors may differ from human
• Metabolism varies between species
• Immune responses differ
• What works in animals may fail in humans

Technical Challenges

• Many variables to control
• Expensive and time-consuming
• Requires specialized facilities
• Ethical considerations

Translation from In Vivo to Humans

What Translates Well

• Mechanism of action
• Target engagement
• General pharmacology

What May Not Translate

• Exact doses
• Side effect profiles
• Efficacy magnitude
• Immunogenicity

Examples in Peptide Research

GLP-1 Agonists

• In vivo mouse studies showed appetite reduction
• Human trials confirmed this effect
• Good translation of mechanism

BPC-157

• Extensive in vivo animal data
• Limited human clinical trial data
• Translation to humans less established

Frequently Asked Questions

Why test in animals before humans?

Animal testing helps identify safety issues before human exposure. It provides data on absorption, distribution, metabolism, and excretion that can’t be obtained in vitro. Regulatory agencies require animal safety data before human trials can begin.

Do animal results always predict human results?

No. Animals and humans differ in genetics, metabolism, and physiology. About 90% of drugs that work in animals fail in human trials. However, animal studies remain valuable for identifying mechanisms and safety signals.

What’s the 3Rs in animal research?

Replacement (use alternatives when possible), Reduction (use minimum animals needed), and Refinement (minimize suffering). These principles guide ethical animal research and are increasingly emphasized in regulations.